Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $625.83 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $137.54 | 1 | $0 (2019) |
| Relypsa, Inc. | $124.93 | 1 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $122.43 | 1 | $0 (2024) |
| Insmed, Inc. | $120.97 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $119.96 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.43 | 1 | Mallinckrodt Hospital Products Inc. ($122.43) |
| 2019 | $503.40 | 4 | Genentech USA, Inc. ($137.54) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $122.43 | General |
| Category: CRITICAL CARE | ||||||
| 04/10/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $137.54 | General |
| 04/06/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $120.97 | General |
| Category: Respiratory | ||||||
| 04/03/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $124.93 | General |
| Category: Hyperkalemia | ||||||
| 03/07/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $119.96 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 95 | 96 | $51,840 | $11,875 |
| 2022 | 1 | 110 | 116 | $62,640 | $14,999 |
| 2021 | 1 | 89 | 89 | $48,060 | $10,624 |
| 2020 | 1 | 104 | 105 | $56,700 | $12,472 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 95 | 96 | $51,840 | $11,875 | 22.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 110 | 116 | $62,640 | $14,999 | 23.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 89 | 89 | $48,060 | $10,624 | 22.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 104 | 105 | $56,700 | $12,472 | 22.0% |
About Dr. Sassan Andalibi, M.D
Dr. Sassan Andalibi, M.D is a Chronic Disease Hospital healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2016. The National Provider Identifier (NPI) number assigned to this provider is 1295186526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sassan Andalibi, M.D has received a total of $625.83 in payments from pharmaceutical and medical device companies, with $122.43 received in 2024. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($625.83).
As a Medicare-enrolled provider, Andalibi has provided services to 398 Medicare beneficiaries, totaling 406 services with total Medicare billing of $49,970. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Chronic Disease Hospital
- Other Specialties Hospitalist
- Location New York, NY
- Active Since 06/28/2016
- Last Updated 07/17/2019
- Taxonomy Code 281P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295186526
Products in Payments
- Veltassa (Drug) $124.93
- TERLIVAZ (Drug) $122.43
- Arikayce (Drug) $120.97
- ELIQUIS (Drug) $119.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Chronic Disease Hospital Doctors in New York
Maria Giovanna Trivieri, Md, Phd, MD, PHD
Chronic Disease Hospital — Payments: $19,620
Dr. Allan Bahoric, M.d, M.D
Chronic Disease Hospital
Dr. Sohail Tavazoie, M.d, M.D
Chronic Disease Hospital
Dr. Sarah Johnson, Md, Frcpc, MD, FRCPC
Chronic Disease Hospital
Paul Foran, Mb Bch Bap, MB BCH BAP
Chronic Disease Hospital
Elizabeth Lutale
Chronic Disease Hospital